J&J and Merck Ebola vaccines produce lasting antibodies in children and adults - studies

J&J and Merck Ebola vaccines produce lasting antibodies in children and adults -studies Ebola vaccines developed by Johnson & Johnson and Merck & Co produced virus-fighting antibodies and appear to be safe in children and adults, according to data from two studies published on Wednesday. Nandhini Srinivasan,Leroy Leo Reuters

...

Both companies' vaccines produced antibodies 14 days after the first of two shots and were detectable at varying levels in both children and adults for one year, data from the studies conducted in Western Africa showed.

...